J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p 
HP Stock Drops 9% Despite Q3 Earnings Beat and Raised 2026 Outlook 
Trump Administration Plans New Drug Pricing Deals With Biotech Firms 
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone 
Meta Agrees to $18 Billion Settlement, Tightens Teen Social Media Rules 
Tesla Raises Cybertruck Prices by $5,000 in US 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
Trump Buys SpaceX Shares After Record IPO 
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing 
SK Hynix Shares Fall as Workers Reject Wage Deal 
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny 
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
SEC Probes Banks Over Situational Awareness Hedge Fund Collapse 
Nvidia Options Price in $280 Billion Earnings Swing 
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook 
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake 
Add as a preferred source on Google
BRISBANE, Calif., April 26, 2018 -- Cutera, Inc. (Nasdaq:CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, Chief Executive Officer, Sandra Gardiner, Chief Financial Officer, and Matthew Scalo, Vice President, Investor Relations & Corporate Development, will present at the 2018 UBS Global Healthcare Conference on Wednesday, May 23rd at the Grand Hyatt New York.
The Company is scheduled to present on Wednesday, May 23, 2018 at 9:00 AM ET. A live audio webcast and slides of the presentation will be made available at the Investor Relations section of the Company’s website, www.cutera.com.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of laser, light and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
CONTACTS:
Cutera, Inc.
Matthew Scalo
Vice President, Investor Relations & Corporate Development
415-657-5500
[email protected]
Investor Relations
John Mills
Integrated Corporate Relations, Inc.
646-277-1254
[email protected]
